Lexmark announced that it has received 510(k) Class II clearance from the US Food and Drug Administration (FDA) for Lexmark NilRead, a web-based, zero-footprint enterprise diagnostic viewer.
The NilRead viewer is available in multiple configurations—core, clinical, and interpretation—covering different workflows ranging from the distribution of imaging studies and reports within the enterprise to full primary interpretation workflows in decoupled enterprise image management implementations.
According to Lexmark, each NilRead configuration provides physicians with secure, interactive processing, viewing, and sharing of 2D, MPR, 3D, and Fusion radiology exams. It provides interactive image processing and visualization tools and rule-based exam viewing to support physician preference and multi-monitor display configuration. NilRead can be easily integrated with any DICOM or HL7 network, connected with a vendor neutral archive (VNA), and invoked from a radiology information system (RIS) or workflow/reporting solution. NilRead can also query-retrieve remote DICOM and Web DICOM nodes, XDS repositories and other medical archives.
Lexmark NilRead functions as an enterprise viewing solution that gives clinicians universal access to all patient imaging through the EMR, electronic health record (EHR), or health information exchange (HIE). NilRead also supports dedicated interpretation workflows for radiology and other specific departments. It is designed to enable referring physicians and diagnosticians to work together more effectively to treat patients without the constraints of service line silos. The aim is for clinicians to quickly and efficiently access and interact with images and reports for all patient images in a single view across the enterprise.
For more information, visit the Lexmark website.
